Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 2Phase EARLY_PHASE1 2Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 433Neoplasms 371Prostatic Neoplasms 206Lung Neoplasms 195Colorectal Neoplasms 151Motor Activity 94Uterine Cervical Neoplasms 83Pancreatic Neoplasms 78Carcinoma, Non-Small-Cell Lung 75Head and Neck Neoplasms 74Brain Neoplasms 69Ovarian Neoplasms 65Carcinoma, Hepatocellular 53Colonic Neoplasms 51Rectal Neoplasms 50Neoplasm Metastasis 50Anxiety Disorders 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Glioblastoma 43Hematologic Neoplasms 42Depression 41Melanoma 37Glioma 37Disease 37Stomach Neoplasms 35Sarcoma 35Multiple Myeloma 34Pain 32Carcinoma, Renal Cell 32Lymphoma 31

Interventions

Specimen Handling 1Glucose 1Contrast Media 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Pancreatic Ductal Adenocarcinoma × 90 days × Clear all
NCT05296421 2026-05-04

Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

Rutgers, The State University of New Jersey

Phase NA Recruiting
16 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07324096 2026-03-27

AI-PACED

Mayo Clinic

Phase NA Recruiting
100 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡